Lubet R A, Capdevila J, Prough R A
Int J Cancer. 1979 Mar 15;23(3):353-7. doi: 10.1002/ijc.2910230313.
A rat liver microsome-mediated bacterial mutagenicity test showed 9-hyroxybenzo(a)pyrene to be significantly more effective as a pre-mutagen than benzo(a)pyrene. Experiments measuring the ability of these compounds to be metabolically activated to moieties that alkylate exogenous DNA demonstrated that 9-hydroxybenzo(a)pyrene was almost six times more effective than benzo(a)pyrene itself. Addition of trichloropropene-2,3-oxide to the reaction mixture enhanced the mutagenicity and DNA alkylation by benzo(a)pyrene but had little or no effect on the 9-hydroxybenzo(a)pyrene-mediated mutagenicity and alkylation. On the other hand, 7,8-benzoflavone inhibited the microsome-mediated mutagenicity and DNA alkylating activity of both hydrocarbons.
大鼠肝微粒体介导的细菌致突变性试验表明,9-羟基苯并(a)芘作为前诱变剂比苯并(a)芘的效果显著更强。测量这些化合物代谢活化为能使外源DNA烷基化的部分的能力的实验表明,9-羟基苯并(a)芘的效果几乎是苯并(a)芘本身的六倍。向反应混合物中添加三氯丙烯-2,3-氧化物可增强苯并(a)芘的致突变性和DNA烷基化作用,但对9-羟基苯并(a)芘介导的致突变性和烷基化作用几乎没有影响。另一方面,7,8-苯并黄酮抑制了这两种碳氢化合物的微粒体介导的致突变性和DNA烷基化活性。